메뉴 건너뛰기




Volumn 9, Issue 9, 2013, Pages 1337-1352

Circulating tumor cells: Utopia or reality?

Author keywords

circulating tumor cell; detection method; epithelial mesenchymal transition; metastasis; molecular characterization; prognosis

Indexed keywords

ANGIOPOIETIN 2; BETA CATENIN; DNA FRAGMENT; EPITHELIAL CELL ADHESION MOLECULE; FIBRONECTIN; HYPOXIA INDUCIBLE FACTOR; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN; SMOOTH MUSCLE ACTIN; UVOMORULIN; VASCULOTROPIN A; VIMENTIN;

EID: 84883269129     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.101     Document Type: Review
Times cited : (20)

References (109)
  • 1
    • 0036674501 scopus 로고    scopus 로고
    • Dissemination and growth of cancer cells in metastatic sites
    • Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2(8), 563-572 (2002
    • (2002) Nat. Rev. Cancer , vol.2 , Issue.8 , pp. 563-572
    • Chambers, A.F.1    Groom, A.C.2    MacDonald, I.C.3
  • 2
    • 33745303045 scopus 로고    scopus 로고
    • Hypoxia signaling in cancer and approaches to enforce tumour regression
    • Pouyssegur J, Dayan F, Mazure NM. Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441(7092), 437-443 (2006
    • (2006) Nature , vol.441 , Issue.7092 , pp. 437-443
    • Pouyssegur, J.1    Dayan, F.2    Mazure, N.M.3
  • 3
    • 31044433663 scopus 로고    scopus 로고
    • Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
    • Condeelis J, Pollard JW. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2), 263-266 (2006
    • (2006) Cell , vol.124 , Issue.2 , pp. 263-266
    • Condeelis, J.1    Pollard, J.W.2
  • 4
    • 84866324123 scopus 로고    scopus 로고
    • Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links
    • Scheela C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links. Semin. Cancer Biol. 22(5-6), 396-403 (2012
    • (2012) Semin. Cancer Biol , vol.22 , Issue.5-6 , pp. 396-403
    • Scheela, C.1    Weinberg, R.A.2
  • 5
    • 79959636906 scopus 로고    scopus 로고
    • The physics of cancer: The role of physical interactions and mechanical forces in metastasis
    • Wirtz D, Konstantopoulos K, Searson PC. The physics of cancer: The role of physical interactions and mechanical forces in metastasis. Nat. Rev. Cancer 11(7), 512-522 (2011
    • (2011) Nat. Rev. Cancer , vol.11 , Issue.7 , pp. 512-522
    • Wirtz, D.1    Konstantopoulos, K.2    Searson, P.C.3
  • 6
    • 33244463813 scopus 로고    scopus 로고
    • Complex networks orchestrate epithelial-mesenchymal transitions
    • Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions, Nat. Rev. Mol. Cell. Biol. 7, 131-142 (2006
    • (2006) Nat. Rev. Mol. Cell. Biol , vol.7 , pp. 131-142
    • Thiery, J.P.1    Sleeman, J.P.2
  • 7
    • 63049123066 scopus 로고    scopus 로고
    • Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits
    • Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9(4), 265-273 (2009
    • (2009) Nat. Rev. Cancer , vol.9 , Issue.4 , pp. 265-273
    • Polyak, K.1    Weinberg, R.A.2
  • 8
    • 22244432840 scopus 로고    scopus 로고
    • The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program
    • De Craene B, Gilbert B, Stove C et al. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res. 65(14), 6237-6244 (2005
    • (2005) Cancer Res , vol.65 , Issue.14 , pp. 6237-6244
    • De Craene, B.1    Gilbert, B.2    Stove, C.3
  • 9
    • 84863357474 scopus 로고    scopus 로고
    • Anoikis resistance: An essential prerequisite for tumor metastasis
    • Kim YN, Koo KH, Sung JY, Yun UJ, Kim H. Anoikis resistance: An essential prerequisite for tumor metastasis. Int. J. Cell Biol. 2012, 306879 (2012
    • (2012) Int. J. Cell Biol , vol.2012 , pp. 306879
    • Kim, Y.N.1    Koo, K.H.2    Sung, J.Y.3    Yun, U.J.4    Kim, H.5
  • 10
    • 59449090107 scopus 로고    scopus 로고
    • TGF-beta-induced epithelial to mesenchymal transition
    • Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19(2), 156-172 (2009
    • (2009) Cell Res , vol.19 , Issue.2 , pp. 156-172
    • Xu, J.1    Lamouille, S.2    Derynck, R.3
  • 11
    • 84867987016 scopus 로고    scopus 로고
    • Molecular characterization of circulating tumor cells in breast cancer: Challenges and promises for individualized cancer treatment
    • Lianidou ES, Markou A, Strati A. Molecular characterization of circulating tumor cells in breast cancer: Challenges and promises for individualized cancer treatment. Cancer Metastasis Rev. 31(3-4), 663-671 (2012
    • (2012) Cancer Metastasis Rev , vol.31 , Issue.3-4 , pp. 663-671
    • Lianidou, E.S.1    Markou, A.2    Strati, A.3
  • 12
    • 84861802693 scopus 로고    scopus 로고
    • MicroRNAs: Critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression
    • Bullock MD, Sayan AE, Packham GK, Mirnezami AH. MicroRNAs: Critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol. Cell. 104(1), 3-12 (2012
    • (2012) Biol. Cell , vol.104 , Issue.1 , pp. 3-12
    • Bullock, M.D.1    Sayan, A.E.2    Packham, G.K.3    Mirnezami, A.H.4
  • 13
    • 43049165453 scopus 로고    scopus 로고
    • The epithelial-mesenchymal transition generates cells with properties of stem cells
    • Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4), 704-715 (2008
    • (2008) Cell , vol.133 , Issue.4 , pp. 704-715
    • Mani, S.A.1    Guo, W.2    Liao, M.J.3
  • 14
    • 35548936833 scopus 로고    scopus 로고
    • Models, mechanisms and clinical evidence for cancer dormancy
    • Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7(11), 834-846 (2007
    • (2007) Nat. Rev. Cancer , vol.7 , Issue.11 , pp. 834-846
    • Aguirre-Ghiso, J.A.1
  • 15
    • 50549121134 scopus 로고
    • The distribution of secondary growths in cancer of the breast
    • Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1, 571-573 (1889
    • (1889) Lancet , vol.1 , pp. 571-573
    • Paget, S.1
  • 16
    • 0004182442 scopus 로고
    • 6th Edition). WB Saunders PA USA
    • Ewing J. Neoplastic Diseases (6th Edition). WB Saunders, PA, USA (1928
    • (1928) Neoplastic Diseases
    • Ewing, J.1
  • 17
    • 0000110505 scopus 로고
    • A case of cancer in which cells similar to those in the tumors were seen in the blood after death
    • Ashworth T. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Australian Med. J. 14, 146 (1869
    • (1869) Australian Med. J. , vol.14 , pp. 146
    • Ashworth, T.1
  • 18
    • 0031655802 scopus 로고    scopus 로고
    • Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases
    • Luzzi KJ, MacDonald IC, Schmidt EE et al. Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153(3), 865-873 (1998
    • (1998) Am. J. Pathol , vol.153 , Issue.3 , pp. 865-873
    • Luzzi, K.J.1    MacDonald, I.C.2    Schmidt, E.E.3
  • 19
    • 0014865396 scopus 로고
    • Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2′-deoxyuridine
    • Fidler IJ. Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773-782 (1970
    • (1970) J. Natl Cancer Inst , vol.45 , pp. 773-782
    • Fidler, I.J.1
  • 20
    • 63049102497 scopus 로고    scopus 로고
    • Parallel progression of primary tumours and metastases
    • Klein CA. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9(4), 302-312 (2009
    • (2009) Nat. Rev. Cancer , vol.9 , Issue.4 , pp. 302-312
    • Klein, C.A.1
  • 21
    • 42649100970 scopus 로고    scopus 로고
    • Detection, clinical relevance and specific biological properties of disseminating tumour cells
    • Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8(5), 329-340 (2008
    • (2008) Nat. Rev. Cancer , vol.8 , Issue.5 , pp. 329-340
    • Pantel, K.1    Brakenhoff, R.H.2    Brandt, B.3
  • 22
    • 79551693066 scopus 로고    scopus 로고
    • Circulating tumor cells: Approaches to isolation and characterization
    • Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: Approaches to isolation and characterization. J. Cell. Biol. 192(3), 373-382 (2011
    • (2011) J. Cell. Biol , vol.192 , Issue.3 , pp. 373-382
    • Yu, M.1    Stott, S.2    Toner, M.3    Maheswaran, S.4    Haber, D.A.5
  • 23
    • 0027235985 scopus 로고
    • Differential expression of proliferation associated molecules in individual micrometastatic carcinoma cells
    • Pantel K, Schlimok G, Braun S et al. Differential expression of proliferation associated molecules in individual micrometastatic carcinoma cells. J. Natl Cancer Inst. 85, 1419-1424 (1993
    • (1993) J. Natl Cancer Inst , vol.85 , pp. 1419-1424
    • Pantel, K.1    Schlimok, G.2    Braun, S.3
  • 24
    • 77953015030 scopus 로고    scopus 로고
    • Isolation and characterization of circulating tumor cells from localized and metastatic prostate cancer patients
    • 25ra23
    • Stott SL, Lee RJ, Nagrath S et al. Isolation and characterization of circulating tumor cells from localized and metastatic prostate cancer patients. Sci. Transl. Med. 2, 25ra23 (2010
    • (2010) Sci. Transl. Med , vol.2
    • Stott, S.L.1    Lee, R.J.2    Nagrath, S.3
  • 25
    • 79151479127 scopus 로고    scopus 로고
    • Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
    • Effenberger KE, Borgen E, Eulenburg CZ et al. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern. Breast Cancer Res. Treat. 125(3), 729-738 (2011
    • (2011) Breast Cancer Res. Treat , vol.125 , Issue.3 , pp. 729-738
    • Effenberger, K.E.1    Borgen, E.2    Eulenburg, C.Z.3
  • 26
    • 47949114668 scopus 로고    scopus 로고
    • Detection of mutations in EGFR in circulating lung-cancer cells
    • Maheswaran S, Sequist LV, Nagrath S et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med. 359(4), 366-377 (2008
    • (2008) N. Engl. J. Med , vol.359 , Issue.4 , pp. 366-377
    • Maheswaran, S.1    Sequist, L.V.2    Nagrath, S.3
  • 27
    • 84861873500 scopus 로고    scopus 로고
    • Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients
    • Rack B, Bock C, Andergassen U, Doisneau-Sixou S. Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients. Histol. Histopathol. 27(7), 855-864 (2012
    • (2012) Histol. Histopathol , vol.27 , Issue.7 , pp. 855-864
    • Rack, B.1    Bock, C.2    Andergassen, U.3    Doisneau-Sixou, S.4
  • 28
    • 84860455199 scopus 로고    scopus 로고
    • Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device
    • Kirby BJ, Jodari M, Loftus MS et al. Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. PLoS One 7(4), e35976 (2012
    • (2012) PLoS One , vol.7 , Issue.4
    • Kirby, B.J.1    Jodari, M.2    Loftus, M.S.3
  • 29
    • 21544473185 scopus 로고    scopus 로고
    • Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells
    • Borgen E, Naume B, Nesland JM et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1(5), 377-388 (1999
    • (1999) Cytotherapy , vol.1 , Issue.5 , pp. 377-388
    • Borgen, E.1    Naume, B.2    Nesland, J.M.3
  • 31
    • 79952239863 scopus 로고    scopus 로고
    • Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay
    • Markou A, Strati A, Malamos N, Georgoulias V, Lianidou ES. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay. Clin. Chem. 57(3), 421-430 (2011
    • (2011) Clin. Chem , vol.57 , Issue.3 , pp. 421-430
    • Markou, A.1    Strati, A.2    Malamos, N.3    Georgoulias, V.4    Lianidou, E.S.5
  • 32
    • 35848955428 scopus 로고    scopus 로고
    • ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
    • Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 1(5), 555-567 (2007
    • (2007) Cell Stem Cell , vol.1 , Issue.5 , pp. 555-567
    • Ginestier, C.1    Hur, M.H.2    Charafe-Jauffret, E.3
  • 33
    • 3042552362 scopus 로고    scopus 로고
    • HER-2 gene amplification can be acquired as breast cancer progresses
    • Meng S, Tripathy D, Shete S et al. HER-2 gene amplification can be acquired as breast cancer progresses. Proc. Natl Acad. Sci. USA 101(25), 9393-9388 (2004
    • (2004) Proc. Natl Acad. Sci. USA , vol.101 , Issue.25 , pp. 9393-9388
    • Meng, S.1    Tripathy, D.2    Shete, S.3
  • 34
    • 40449098857 scopus 로고    scopus 로고
    • Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
    • Fehm T, Becker S, Duerr-Stoerzer S et al. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status. Breast Cancer Res. 9(5), R74 (2007
    • (2007) Breast Cancer Res , vol.9 , Issue.5
    • Fehm, T.1    Becker, S.2    Duerr-Stoerzer, S.3
  • 35
    • 0033891393 scopus 로고    scopus 로고
    • Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells
    • Vona G, Sabile A, Louha M et al. Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 156(1), 57-63 (2000
    • (2000) Am. J. Pathol , vol.156 , Issue.1 , pp. 57-63
    • Vona, G.1    Sabile, A.2    Louha, M.3
  • 37
    • 84863100828 scopus 로고    scopus 로고
    • Considerations in the development of circulating tumor cell technology for clinical use
    • Parkinson DR, Dracopoli N, Gumbs Petty B et al. Considerations in the development of circulating tumor cell technology for clinical use. J. Transl. Med. 10(1), 138 (2012
    • (2012) J. Transl. Med , vol.10 , Issue.1 , pp. 138
    • Parkinson, D.R.1    Dracopoli, N.2    Gumbs Petty, B.3
  • 38
    • 34547529462 scopus 로고    scopus 로고
    • Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells
    • Zheng S, Lin H, Liu JQ et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J. Chromatogr. A 1162(2), 154-161 (2007
    • (2007) J. Chromatogr , vol.A 1162 , Issue.2 , pp. 154-161
    • Zheng, S.1    Lin, H.2    Liu, J.Q.3
  • 39
    • 77958037272 scopus 로고    scopus 로고
    • Portable filter-based microdevice for detection and characterization of circulating tumor cells
    • Lin HK, Zheng S, Williams AJ et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res. 16(20), 5011-5018 (2010
    • (2010) Clin. Cancer Res , vol.16 , Issue.20 , pp. 5011-5018
    • Lin, H.K.1    Zheng, S.2    Williams, A.J.3
  • 40
    • 77955744007 scopus 로고    scopus 로고
    • A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter
    • Xu T, Lu B, Tai YC, Goldkorn A. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res. 70(16), 6420-6642 (2010
    • (2010) Cancer Res , vol.70 , Issue.16 , pp. 6420-6642
    • Xu, T.1    Lu, B.2    Tai, Y.C.3    Goldkorn, A.4
  • 41
    • 79751533744 scopus 로고    scopus 로고
    • 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood
    • Zheng S, Lin HK, Liu JQ et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed. Microdevices 13(1), 203-213 (2011
    • (2011) Biomed. Microdevices , vol.13 , Issue.1 , pp. 203-213
    • Zheng, S.1    Lin, H.K.2    Liu, J.Q.3
  • 42
    • 0041780998 scopus 로고    scopus 로고
    • Detection of circulating tumor cells in blood using an optimized density gradient centrifugation
    • Gertler R, Rosenberg R, Fuehrer K et al. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res. 162, 149-155 (2003
    • (2003) Recent Results Cancer Res , vol.162 , pp. 149-155
    • Gertler, R.1    Rosenberg, R.2    Fuehrer, K.3
  • 43
    • 79961170499 scopus 로고    scopus 로고
    • Circulating tumor cells: Advances in detection methods, biological issues, and clinical relevance
    • Sun YF, Yang XR, Zhou J et al. Circulating tumor cells: Advances in detection methods, biological issues, and clinical relevance. J. Cancer Res. Clin. Oncol. 137(8), 1151-1173 (2011
    • (2011) J. Cancer Res. Clin. Oncol , vol.137 , Issue.8 , pp. 1151-1173
    • Sun, Y.F.1    Yang, X.R.2    Zhou, J.3
  • 44
    • 77954624770 scopus 로고    scopus 로고
    • Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer
    • Miller MC, Doyle GV, Terstappen LW. Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. J. Oncol. 2010, 617421 (2010
    • (2010) J. Oncol , vol.2010 , pp. 617421
    • Miller, M.C.1    Doyle, G.V.2    Terstappen, L.W.3
  • 45
    • 33847402612 scopus 로고    scopus 로고
    • Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system
    • Riethdorf S, Fritsche H, Müller V et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system. Clin. Cancer Res.13(3), 920-928 (2007
    • (2007) Clin. Cancer Res , vol.13 , Issue.3 , pp. 920-928
    • Riethdorf, S.1    Fritsche, H.2    Müller, V.3
  • 46
    • 4143094988 scopus 로고    scopus 로고
    • Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    • Cristofanilli M, Budd GT, Ellis MJ et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351(8), 781-791 (2004
    • (2004) N. Engl. J. Med , vol.351 , Issue.8 , pp. 781-791
    • Cristofanilli, M.1    Budd, G.T.2    Ellis, M.J.3
  • 47
    • 37549002543 scopus 로고    scopus 로고
    • Isolation of rare circulating tumour cells in cancer patients by microchip technology
    • Nagrath S, Sequist LV, Maheswaran S et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173), 1235-1239 (2007
    • (2007) Nature , vol.450 , Issue.7173 , pp. 1235-1239
    • Nagrath, S.1    Sequist, L.V.2    Maheswaran, S.3
  • 48
    • 78649872067 scopus 로고    scopus 로고
    • Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
    • Stott SL, Hsu CH, Tsukrovet DI et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl Acad. Sci. USA 107(43), 18392-18397 (2010
    • (2010) Proc. Natl Acad. Sci. USA , vol.107 , Issue.43 , pp. 18392-18397
    • Stott, S.L.1    Hsu, C.H.2    Tsukrovet, D.I.3
  • 49
    • 4644308683 scopus 로고    scopus 로고
    • Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay
    • Fabisiewicz A, Kulik J, Kober P et al. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase- polymerase chain reaction assay. Acta Biochim. Pol. 51(3), 747-755 (2004
    • (2004) Acta Biochim. Pol , vol.51 , Issue.3 , pp. 747-755
    • Fabisiewicz, A.1    Kulik, J.2    Kober, P.3
  • 50
    • 75549091434 scopus 로고    scopus 로고
    • Circulating tumour cell detection: A direct comparison between the cellsearch system, the adnatest and ck-19/mammaglobin rt-pcr in patients with metastatic breast cancer
    • Van der Auwera I, Peeters D, Benoy IH et al. Circulating tumour cell detection: A direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br. J. Cancer 102(2), 276-284 (2010
    • (2010) Br. J. Cancer , vol.102 , Issue.2 , pp. 276-284
    • Van Der Auwera, I.1    Peeters, D.2    Benoy, I.H.3
  • 51
    • 33847643776 scopus 로고    scopus 로고
    • Quantification of mRNA using real-time RT-PCR
    • Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nature Protoc. 1, 1559-1582 (2006
    • (2006) Nature Protoc , vol.1 , pp. 1559-1582
    • Nolan, T.1    Hands, R.E.2    Bustin, S.A.3
  • 52
    • 26044436866 scopus 로고    scopus 로고
    • Standardized quantification of circulating peripheral tumor cells from lung and breast cancer
    • Pachmann K, Clement JH, Schneider CP et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin. Chem. Lab. Med. 43, 617-627 (2005
    • (2005) Clin. Chem. Lab. Med , vol.43 , pp. 617-627
    • Pachmann, K.1    Clement, J.H.2    Schneider, C.P.3
  • 53
    • 27444444117 scopus 로고    scopus 로고
    • Increase in number of circulating disseminated epithelial cells after surgery for nonsmall cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: A preliminary report
    • Rolle A, Günzel R, Pachmann U, Willen B, Höffken K, Pachmann K. Increase in number of circulating disseminated epithelial cells after surgery for nonsmall cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: A preliminary report. World J. Surg. Oncol. 3, 18 (2005
    • (2005) World J. Surg. Oncol , vol.3 , pp. 18
    • Rolle, A.1    Günzel, R.2    Pachmann, U.3    Willen, B.4    Höffken, K.5    Pachmann, K.6
  • 54
    • 33645243378 scopus 로고    scopus 로고
    • High speed detection of circulating tumor cells
    • Hsieh HB, Marrinucci D, Bethel K et al. High speed detection of circulating tumor cells. Biosens. Bioelectron. 21(10), 1893-1899 (2006
    • (2006) Biosens. Bioelectron , vol.21 , Issue.10 , pp. 1893-1899
    • Hsieh, H.B.1    Marrinucci, D.2    Bethel, K.3
  • 55
    • 84860571431 scopus 로고    scopus 로고
    • EPISPOT assay: Detection of viable DTCs/CTCs in solid tumor patients
    • Alix-Panabières C. EPISPOT assay: Detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res. 195, 69-76 (2012
    • (2012) Recent Results Cancer Res , vol.195 , pp. 69-76
    • Alix-Panabières, C.1
  • 56
    • 73449098612 scopus 로고    scopus 로고
    • Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients
    • Lu J, Fan T, Zhao Q et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int. J. Cancer 126(3), 669-683 (2010
    • (2010) Int. J. Cancer , vol.126 , Issue.3 , pp. 669-683
    • Lu, J.1    Fan, T.2    Zhao, Q.3
  • 57
    • 79957458567 scopus 로고    scopus 로고
    • Cell-free nucleic acids as biomarkers in cancer patients
    • Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11, 426-437 (2011
    • (2011) Nat. Rev. Cancer , vol.11 , pp. 426-437
    • Schwarzenbach, H.1    Hoon, D.S.2    Pantel, K.3
  • 58
    • 61349121505 scopus 로고    scopus 로고
    • Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer
    • Schwarzenbach H, Alix-Panabières C, Müller I et al. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin. Cancer Res. 15(3), 1032-1038 (2009
    • (2009) Clin. Cancer Res , vol.15 , Issue.3 , pp. 1032-1038
    • Schwarzenbach, H.1    Alix-Panabières, C.2    Müller, I.3
  • 60
    • 67650354361 scopus 로고    scopus 로고
    • Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
    • Cohen SJ, Punt CJ, Iannotti N et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann. Oncol. 20(7), 1223-1229 (2009
    • (2009) Ann. Oncol , vol.20 , Issue.7 , pp. 1223-1229
    • Cohen, S.J.1    Punt, C.J.2    Iannotti, N.3
  • 61
    • 58149165081 scopus 로고    scopus 로고
    • Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
    • de Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14(19), 6302-6309 (2008
    • (2008) Clin. Cancer Res , vol.14 , Issue.19 , pp. 6302-6309
    • De Bono, J.S.1    Scher, H.I.2    Montgomery, R.B.3
  • 62
    • 33846814619 scopus 로고    scopus 로고
    • Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
    • Hayes DF, Cristofanilli M, Budd GT et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res. 12, 4218-4224 (2006
    • (2006) Clin Cancer Res , vol.12 , pp. 4218-4224
    • Hayes, D.F.1    Cristofanilli, M.2    Budd, G.T.3
  • 63
    • 33751272999 scopus 로고    scopus 로고
    • Circulating tumor cells versus imaging -Predicting overall survival in metastatic breast cancer
    • Budd GT, Cristofanilli M, Ellis MJ et al. Circulating tumor cells versus imaging -Predicting overall survival in metastatic breast cancer. Clin Cancer Res. 12, 6403-6409 (2006
    • (2006) Clin Cancer Res , vol.12 , pp. 6403-6409
    • Budd, G.T.1    Cristofanilli, M.2    Ellis, M.J.3
  • 64
    • 77951707834 scopus 로고    scopus 로고
    • Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
    • Bidard FC, Mathiot C, Delaloge S et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann. Oncol. 21(4), 729-733 (2010
    • (2010) Ann. Oncol , vol.21 , Issue.4 , pp. 729-733
    • Bidard, F.C.1    Mathiot, C.2    Delaloge, S.3
  • 65
    • 84863105627 scopus 로고    scopus 로고
    • Circulating tumour cells in non-metastatic breast cancer: A prospective study
    • Lucci A, Hall CS, Lodhi AK et al. Circulating tumour cells in non-metastatic breast cancer: A prospective study. Lancet Oncol. 13(7), 688-695 (2012
    • (2012) Lancet Oncol , vol.13 , Issue.7 , pp. 688-695
    • Lucci, A.1    Hall, C.S.2    Lodhi, A.K.3
  • 66
    • 80855132446 scopus 로고    scopus 로고
    • Minimal residual disease and circulating tumor cells in breast cancer
    • Ignatiadis M, Reinholz M. Minimal residual disease and circulating tumor cells in breast cancer. Breast Cancer Res. 13(5), 222 (2011
    • (2011) Breast Cancer Res , vol.13 , Issue.5 , pp. 222
    • Ignatiadis, M.1    Reinholz, M.2
  • 67
    • 58149269229 scopus 로고    scopus 로고
    • Comparison of bone marrow, disseminated tumour cells and blood circulating tumour cells in breast cancer patients after primary treatment
    • Slade MJ, Payne R, Riethdorf S et al. Comparison of bone marrow, disseminated tumour cells and blood circulating tumour cells in breast cancer patients after primary treatment. Br. J. Cancer 100(1), 160-166 (2009
    • (2009) Br. J. Cancer , vol.100 , Issue.1 , pp. 160-166
    • Slade, M.J.1    Payne, R.2    Riethdorf, S.3
  • 68
    • 79958295369 scopus 로고    scopus 로고
    • The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
    • Molloy TJ, Bosma AJ, Baumbusch LO et al. The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients. Breast Cancer Res. 13(3), R61 (2011
    • (2011) Breast Cancer Res , vol.13 , Issue.3
    • Molloy, T.J.1    Bosma, A.J.2    Baumbusch, L.O.3
  • 69
    • 34447302323 scopus 로고    scopus 로고
    • Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage i and II breast cancer after the administration of adjuvant chemotherapy: Evaluation of their clinical relevance
    • Apostolaki S, Perraki M, Pallis A et al. Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: Evaluation of their clinical relevance. Ann. Oncol. 18(5), 851-858 (2007
    • (2007) Ann. Oncol , vol.18 , Issue.5 , pp. 851-858
    • Apostolaki, S.1    Perraki, M.2    Pallis, A.3
  • 70
    • 77951740458 scopus 로고    scopus 로고
    • Detection and her2 expression of circulating tumor cells: Prospective monitoring in breast cancer patients treated in the neoadjuvant geparquattro trial
    • Riethdorf S, Muller V, Zhang L et al. Detection and HER2 expression of circulating tumor cells: Prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin. Cancer Res. 16(9), 2634-2645 (2010
    • (2010) Clin. Cancer Res , vol.16 , Issue.9 , pp. 2634-2645
    • Riethdorf, S.1    Muller, V.2    Zhang, L.3
  • 71
    • 57049162148 scopus 로고    scopus 로고
    • Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a Phase II randomized trial
    • Pierga JY, Bidard FC, Mathiot C et al. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a Phase II randomized trial. Clin. Cancer Res. 14(21), 7004-7010 (2008
    • (2008) Clin. Cancer Res , vol.14 , Issue.21 , pp. 7004-7010
    • Pierga, J.Y.1    Bidard, F.C.2    Mathiot, C.3
  • 72
    • 78951472024 scopus 로고    scopus 로고
    • Epidermal growth factor receptor (EGFR) mutation, analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
    • Peraldo-Neia C, Migliardi G, Mello-Grand M et al. Epidermal growth factor receptor (EGFR) mutation, analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. BMC Cancer 11, 31 (2011
    • (2011) BMC Cancer , vol.11 , pp. 31
    • Peraldo-Neia, C.1    Migliardi, G.2    Mello-Grand, M.3
  • 73
    • 77950591041 scopus 로고    scopus 로고
    • Cancer stemness and metastasis: Therapeutic consequences and perspectives
    • Monteiro J, Fodde R. Cancer stemness and metastasis: Therapeutic consequences and perspectives. Eur. J. Cancer 46(7), 1198-1203 (2010
    • (2010) Eur. J. Cancer , vol.46 , Issue.7 , pp. 1198-1203
    • Monteiro, J.1    Fodde, R.2
  • 74
    • 33847327128 scopus 로고    scopus 로고
    • Chronic oxaliplatin resistance induces epithelial-to mesenchymal transition in colorectal cancer cell lines
    • Yang AD, Fan F, Camp ER et al. Chronic oxaliplatin resistance induces epithelial-to mesenchymal transition in colorectal cancer cell lines. Clin. Cancer Res. 12(14 Pt 1), 4147-4153 (2006
    • (2006) Clin. Cancer Res , vol.12 , Issue.14 PART 1 , pp. 4147-4153
    • Yang, A.D.1    Fan, F.2    Camp, E.R.3
  • 75
    • 35148825636 scopus 로고    scopus 로고
    • Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells
    • Kajiyama H, Shibata K, Terauchi M et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int. J. Oncol. 31(2), 277-283 (2007
    • (2007) Int. J. Oncol , vol.31 , Issue.2 , pp. 277-283
    • Kajiyama, H.1    Shibata, K.2    Terauchi, M.3
  • 76
    • 33947192053 scopus 로고    scopus 로고
    • Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel
    • Cheng GZ, Chan J, Wang Q et al. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res. 67(5), 1979-1987 (2007
    • (2007) Cancer Res , vol.67 , Issue.5 , pp. 1979-1987
    • Cheng, G.Z.1    Chan, J.2    Wang, Q.3
  • 77
    • 77951233874 scopus 로고    scopus 로고
    • Chemosensitivity profile assay of circulating cancer cells (CTCs): Prognostic and predictive value in epithelial tumors
    • Gazzaniga P, Naso G, Gradilone A et al. Chemosensitivity profile assay of circulating cancer cells (CTCs): Prognostic and predictive value in epithelial tumors. Int. J. Cancer 126(10), 2437-2447 (2010
    • (2010) Int. J. Cancer , vol.126 , Issue.10 , pp. 2437-2447
    • Gazzaniga, P.1    Naso, G.2    Gradilone, A.3
  • 78
    • 78650328019 scopus 로고    scopus 로고
    • Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): Prognosis, drug resistance and phenotypic characterization
    • Gradilone A, Naso G, Raimondi C et al. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): Prognosis, drug resistance and phenotypic characterization. Ann. Oncol. 22(1), 86-92 (2011
    • (2011) Ann. Oncol , vol.22 , Issue.1 , pp. 86-92
    • Gradilone, A.1    Naso, G.2    Raimondi, C.3
  • 79
    • 77956268304 scopus 로고    scopus 로고
    • Circulating tumour cells in cancer patients: Challenges and perspectives
    • Pantel K, Alix-Panabières C. Circulating tumour cells in cancer patients: Challenges and perspectives. Trends Mol. Med. 16(9), 398-406 (2010
    • (2010) Trends Mol. Med , vol.16 , Issue.9 , pp. 398-406
    • Pantel, K.1    Alix-Panabières, C.2
  • 80
    • 72549116858 scopus 로고    scopus 로고
    • Circulating tumor cell as a diagnostic marker in primary lung cancer
    • Tanaka F, Yoneda K, Kondo N et al. Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin. Cancer Res. 15(22), 6980-6986 (2009
    • (2009) Clin. Cancer Res , vol.15 , Issue.22 , pp. 6980-6986
    • Tanaka, F.1    Yoneda, K.2    Kondo, N.3
  • 81
    • 79955045007 scopus 로고    scopus 로고
    • Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer
    • Krebs MG, Sloane R, Priest L et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J. Clin. Oncol. 29(12), 1556-1563 (2011
    • (2011) J. Clin. Oncol , vol.29 , Issue.12 , pp. 1556-1563
    • Krebs, M.G.1    Sloane, R.2    Priest, L.3
  • 82
    • 84868106386 scopus 로고    scopus 로고
    • Circulating tumor cells in small-cell lung cancer: A predictive and prognostic factor
    • Hiltermann TJ, Pore MM, van den Berg A et al. Circulating tumor cells in small-cell lung cancer: A predictive and prognostic factor. Ann Oncol. 23(11), 2937-2942 (2012
    • (2012) Ann Oncol , vol.23 , Issue.11 , pp. 2937-2942
    • Hiltermann, T.J.1    Pore, M.M.2    Van Den Berg, A.3
  • 83
    • 84869484580 scopus 로고    scopus 로고
    • Circulating tumor cells measurements in hepatocellular carcinoma
    • Chiappini F. Circulating tumor cells measurements in hepatocellular carcinoma. Int. J. Hepatol. 2012, 684802 (2012
    • (2012) Int. J. Hepatol , vol.2012 , pp. 684802
    • Chiappini, F.1
  • 84
    • 84867399103 scopus 로고    scopus 로고
    • Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer
    • Rossi E, Fassan M, Aieta M et al. Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer. Br. J. Cancer 107(8), 1286-1294 (2012
    • (2012) Br. J. Cancer , vol.107 , Issue.8 , pp. 1286-1294
    • Rossi, E.1    Fassan, M.2    Aieta, M.3
  • 85
    • 79961116885 scopus 로고    scopus 로고
    • Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: Systematic review and meta-analysis
    • Msaouel P, Koutsilieris M. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: Systematic review and meta-analysis. BMC Cancer 11, 336 (2011
    • (2011) BMC Cancer , vol.11 , pp. 336
    • Msaouel, P.1    Koutsilieris, M.2
  • 87
    • 84861344118 scopus 로고    scopus 로고
    • Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch system
    • Nichols AC, Lowes LE, Szeto CC et al. Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch system. Head Neck 34(10), 1440-1444 (2012
    • (2012) Head Neck , vol.34 , Issue.10 , pp. 1440-1444
    • Nichols, A.C.1    Lowes, L.E.2    Szeto, C.C.3
  • 88
    • 79952010767 scopus 로고    scopus 로고
    • Circulating melanoma cells and survival in metastatic melanoma
    • Rao C, Bui T, Connelly M et al. Circulating melanoma cells and survival in metastatic melanoma. Int. J. Oncol. 38(3), 755-760 (2011
    • (2011) Int. J. Oncol , vol.38 , Issue.3 , pp. 755-760
    • Rao, C.1    Bui, T.2    Connelly, M.3
  • 89
    • 79955438082 scopus 로고    scopus 로고
    • Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer
    • Rink M, Chun FK, Minner S et al. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer. BJU Int. 107(10), 1668-1675 (2011
    • (2011) BJU Int , vol.107 , Issue.10 , pp. 1668-1675
    • Rink, M.1    Chun, F.K.2    Minner, S.3
  • 90
    • 84864853480 scopus 로고    scopus 로고
    • Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: A CellSearch analysis
    • Gazzaniga P, Gradilone A, de Berardinis E et al. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: A CellSearch analysis. Ann Oncol. 23(9), 2352-2356 (2012
    • (2012) Ann Oncol , vol.23 , Issue.9 , pp. 2352-2356
    • Gazzaniga, P.1    Gradilone, A.2    De Berardinis, E.3
  • 91
    • 84856317859 scopus 로고    scopus 로고
    • Comparison of assay methods for detection of circulating tumor cells (CTCs) in metastatic breast cancer (MBC): Adnagen adnatest breastcancer select/detect™ versus veridex cellsearch™ system
    • Andreopoulou E, Yang LY, Rangel KM et al. Comparison of assay methods for detection of circulating tumor cells (CTCs) in metastatic breast cancer (MBC): AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system. Int. J. Cancer 130(7), 1590-1597 (2012
    • (2012) Int. J. Cancer , vol.130 , Issue.7 , pp. 1590-1597
    • Andreopoulou, E.1    Yang, L.Y.2    Rangel, K.M.3
  • 92
    • 80052190496 scopus 로고    scopus 로고
    • Circulating tumor cells (CTC) in breast cancer: Detection systems, molecular characterization and future challenges
    • Lianidou ES, Markou A. Circulating tumor cells (CTC) in breast cancer: Detection systems, molecular characterization and future challenges. Clin. Chem. 57(9), 1242-1255 (2011
    • (2011) Clin. Chem , vol.57 , Issue.9 , pp. 1242-1255
    • Lianidou, E.S.1    Markou, A.2
  • 93
    • 82955187028 scopus 로고    scopus 로고
    • Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
    • Raimondi C, Gradilone A, Naso G et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res. Treat. 130(2), 449-455 (2011
    • (2011) Breast Cancer Res. Treat , vol.130 , Issue.2 , pp. 449-455
    • Raimondi, C.1    Gradilone, A.2    Naso, G.3
  • 94
    • 19944426264 scopus 로고    scopus 로고
    • Circulating tumor cells in patients with breast cancer dormancy
    • Meng S, Tripathy D, Frenkel EP et al. Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res. 10, 8152-8162 (2004
    • (2004) Clin. Cancer Res , vol.10 , pp. 8152-8162
    • Meng, S.1    Tripathy, D.2    Frenkel, E.P.3
  • 95
    • 77955082633 scopus 로고    scopus 로고
    • All circulating EpCAM+CK-CD45-objects predict overall survival in castration-resistant prostate cancer
    • Coumans FAW, Doggen CJM, Attard G, de Bono JS, Terstappen LW. All circulating EpCAM+CK-CD45-objects predict overall survival in castration-resistant prostate cancer. Ann. Oncol. 21(9), 1851-1857 (2010
    • (2010) Ann. Oncol , vol.21 , Issue.9 , pp. 1851-1857
    • Coumans, F.A.W.1    Doggen, C.J.M.2    Attard, G.3    De Bono, J.S.4    Terstappen, L.W.5
  • 96
    • 78049485312 scopus 로고    scopus 로고
    • M30 neoepitope expression in epithelial cancer: Quantification of apoptosis in circulating tumor cells by cellsearch analysis
    • Rossi E, Basso U, Celadin R et al. M30 neoepitope expression in epithelial cancer: Quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin. Cancer Res. 16(21), 5233-5243 (2010
    • (2010) Clin. Cancer Res , vol.16 , Issue.21 , pp. 5233-5243
    • Rossi, E.1    Basso, U.2    Celadin, R.3
  • 97
    • 36849069347 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    • Harris L, Fritsche H, Mennel R et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 25, 5287-5312 (2007
    • (2007) J. Clin. Oncol , vol.25 , pp. 5287-5312
    • Harris, L.1    Fritsche, H.2    Mennel, R.3
  • 98
    • 33645221871 scopus 로고    scopus 로고
    • Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer
    • Wiedswang G, Borgen E, Schirmer C et al. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int. J. Cancer 118(8), 2013-2019 (2006
    • (2006) Int. J. Cancer , vol.118 , Issue.8 , pp. 2013-2019
    • Wiedswang, G.1    Borgen, E.2    Schirmer, C.3
  • 99
    • 33644837133 scopus 로고    scopus 로고
    • Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer
    • Benoy IH, Elst H, Philips M et al. Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br. J. Cancer 94(5), 672-680 (2006
    • (2006) Br. J. Cancer , vol.94 , Issue.5 , pp. 672-680
    • Benoy, I.H.1    Elst, H.2    Philips, M.3
  • 100
    • 40149098689 scopus 로고    scopus 로고
    • Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
    • Bidard FC, Vincent-Salomon A, Sigal-Zafrani B et al. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. Ann. Oncol. 19(3), 496-500 (2008
    • (2008) Ann. Oncol , vol.19 , Issue.3 , pp. 496-500
    • Bidard, F.C.1    Vincent-Salomon, A.2    Sigal-Zafrani, B.3
  • 101
    • 84857749998 scopus 로고    scopus 로고
    • Expected clinical applications of circulating tumor cells in breast cancer
    • Park Y, Kitahara T, Urita T, Yoshida Y, Kato R. Expected clinical applications of circulating tumor cells in breast cancer. World J. Clin. Oncol. 2(8), 303-310 (2011
    • (2011) World J. Clin. Oncol , vol.2 , Issue.8 , pp. 303-310
    • Park, Y.1    Kitahara, T.2    Urita, T.3    Yoshida, Y.4    Kato, R.5
  • 102
    • 79951849235 scopus 로고    scopus 로고
    • Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker
    • Hofman V, Bonnetaud C, Ilie MI et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin. Cancer Res. 17(4), 827-835 (2011
    • (2011) Clin. Cancer Res , vol.17 , Issue.4 , pp. 827-835
    • Hofman, V.1    Bonnetaud, C.2    Ilie, M.I.3
  • 103
    • 84883463960 scopus 로고    scopus 로고
    • Metabolic syndrome as a peculiar target for management of prostate cancer patients
    • doi:10.1016/j.clgc.04.009 Epub ahead of print
    • Conteduca V, Di Lorenzo G, Bozza G, Ardito R, Aieta M. Metabolic syndrome as a peculiar target for management of prostate cancer patients. Clin. Genitourin. Cancer doi:10.1016/j.clgc.04.009 (2013) (Epub ahead of print
    • (2013) Clin. Genitourin. Cancer
    • Conteduca, V.1    Di Lorenzo, G.2    Bozza, G.3    Ardito, R.4    Aieta, M.5
  • 104
    • 34250783291 scopus 로고    scopus 로고
    • Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor
    • de Bono JS, Attard G, Adjei A et al. Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor. Clin. Cancer Res. 13(12), 3611-3616 (2007
    • (2007) Clin. Cancer Res , vol.13 , Issue.12 , pp. 3611-3616
    • De Bono, J.S.1    Attard, G.2    Adjei, A.3
  • 105
    • 84860391606 scopus 로고    scopus 로고
    • Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review
    • Ozkan EE. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review. Mol. Cell. Endocrinol. 344, 1-24 (2011
    • (2011) Mol. Cell. Endocrinol , vol.344 , pp. 1-24
    • Ozkan, E.E.1
  • 106
    • 70249150745 scopus 로고    scopus 로고
    • Circulating tumor cells and [18F] fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer
    • De Giorgi U, Valero V, Rohren E et al. Circulating tumor cells and [18F] fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J. Clin. Oncol. 27(20), 3303-3311 (2009
    • (2009) J. Clin. Oncol , vol.27 , Issue.20 , pp. 3303-3311
    • De Giorgi, U.1    Valero, V.2    Rohren, E.3
  • 107
    • 77956194618 scopus 로고    scopus 로고
    • 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer
    • De Giorgi U, Mego M, Rohren EM et al. 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer. J. Nucl. Med. 51(8), 1213-1218 (2010
    • (2010) J. Nucl. Med , vol.51 , Issue.8 , pp. 1213-1218
    • De Giorgi, U.1    Mego, M.2    Rohren, E.M.3
  • 109
    • 55549115023 scopus 로고    scopus 로고
    • Circulating tumor cells in metastatic breast cancer: From prognostic stratification to modification of the staging system?
    • Dawood S, Broglio K, Valero V et al. Circulating tumor cells in metastatic breast cancer: From prognostic stratification to modification of the staging system? Cancer 113(9), 2422-2430 (2008
    • (2008) Cancer , vol.113 , Issue.9 , pp. 2422-2430
    • Dawood, S.1    Broglio, K.2    Valero, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.